Genexine, Top Search Ranking... Stock Price Up 4.1%

Genexine has ranked among the top searched stocks for 13 days in the past month.

As of 2:31 PM on the 26th, Genexine is trading at 147,400 KRW, up 4.1% from the previous day. This marks a 24.92% increase compared to August 12. Genexine is known as a company specializing in the development of biopharmaceuticals.

Today, foreigners have net purchased 93,633 shares of Genexine, while institutions have net sold 5,000 shares, according to preliminary data. Over the past five days, individual investors have net purchased 189,534 shares, whereas foreigners and institutions have net sold 11,398 shares and 28,344 shares, respectively.

On August 25, Genexine became a market issue with the headline "Rise following US FDA Phase 1b approval for lymphoma treatment."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.